2490. Longer-Term Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed Adults Living With HIV and End-Stage Renal Disease on Chronic Hemodialysis

BACKGROUND: HIV treatment for individuals with end-stage renal disease (ESRD) on hemodialysis (HD) has previously required complex dose-adjusted regimens. We evaluated the safety and efficacy of single-tablet, once-daily elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in peop...

Descripción completa

Detalles Bibliográficos
Autores principales: Eron, Joseph J, Lelievre, Jean-Daniel, Kalayjian, Robert, Slim, Jihad, Wurapa, Anson K, Stephens, Jeffrey L, McDonald, Cheryl, Cua, Eric, Wilkin, Arjun, McKellar, Mehri, Cox, Stephanie, Majeed, Sophia, Blair, Christiana, Carter, Christoph C, SenGupta, Devi, Brainard, Diana M, Das, Moupali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809506/
http://dx.doi.org/10.1093/ofid/ofz360.2168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809506/
http://dx.doi.org/10.1093/ofid/ofz360.2168

Ejemplares similares